Table of Content


1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Cardiac Biomarkers Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Type
5.5 Market Breakup by Location of Testing
5.6 Market Breakup by Application
5.7 Market Breakup by Region
5.8 Market Forecast

6 Market Breakup by Type
6.1 Troponins (T and I)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Myocardial Muscle Creatine Kinase (CK-MB)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Myoglobin
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Ischemia Modified Albumin (IMA)
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast

7 Market Breakup by Location of Testing
7.1 Laboratory Testing
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Point of Care Testing
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Application
8.1 Myocardial Infarction
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Congestive Heart Failure
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Acute Coronary Syndrome
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Atherosclerosis
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Asia Pacific
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Europe
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast

10 Global Cardiac Biomarkers Industry: SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Global Cardiac Biomarkers Industry: Value Chain Analysis

12 Global Cardiac Biomarkers Industry: Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Global Cardiac Biomarkers Industry: Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.2 Alere Inc.
14.3.3 Beckman Coulter
14.3.4 Becton, Dickinson And Co.
14.3.5 Biomerieux
14.3.6 Bio-Rad Laboratories
14.3.7 Randox Laboratories
14.3.8 Roche Diagnostics Corporation
14.3.9 Siemens Healthcare
14.3.10 Thermo Fisher Scientific

List of Figures

Figure 1: Global: Cardiac Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Cardiac Biomarkers Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cardiac Biomarkers Market: Breakup by Type (in %), 2022
Figure 4: Global: Cardiac Biomarkers Market: Breakup by Location of Testing (in %), 2022
Figure 5: Global: Cardiac Biomarkers Market: Breakup by Application (in %), 2022
Figure 6: Global: Cardiac Biomarkers Market: Breakup by Region (in %), 2022
Figure 7: Global: Cardiac Biomarkers Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Cardiac Biomarkers Industry: SWOT Analysis
Figure 9: Global: Cardiac Biomarkers Industry: Value Chain Analysis
Figure 10: Global: Cardiac Biomarkers Industry: Porter’s Five Forces Analysis
Figure 11: Global: Cardiac Biomarkers (Troponins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Cardiac Biomarkers (Troponins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Cardiac Biomarkers (Myoglobin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Cardiac Biomarkers (Myoglobin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Cardiac Biomarkers (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Cardiac Biomarkers (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Cardiac Biomarkers (Laboratory Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Cardiac Biomarkers (Laboratory Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Cardiac Biomarkers (Point of Care Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Cardiac Biomarkers (Point of Care Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Cardiac Biomarkers (Myocardial Infarction) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Cardiac Biomarkers (Myocardial Infarction) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Cardiac Biomarkers (Congestive Heart Failure) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Cardiac Biomarkers (Congestive Heart Failure) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Cardiac Biomarkers (Atherosclerosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Cardiac Biomarkers (Atherosclerosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Cardiac Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Cardiac Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: North America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: North America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Asia Pacific: Cardiac Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Asia Pacific: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Europe: Cardiac Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Europe: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Middle East and Africa: Cardiac Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Middle East and Africa: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Latin America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Latin America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028

List of Tables

Table 1: Global: Cardiac Biomarkers Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cardiac Biomarkers Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Cardiac Biomarkers Market Forecast: Breakup by Location of Testing (in Million US$), 2023-2028
Table 4: Global: Cardiac Biomarkers Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Cardiac Biomarkers Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Cardiac Biomarkers Market Structure
Table 7: Global: Cardiac Biomarkers Market: Key Players